Skip to main content

Want a detailed portfolio tracker?

CNTX
NASDAQ
$0.62

Context Therapeutics Inc (CNTX)

Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
Website: https://www.contexttherapeutics.com
Sector:
Healthcare
Industry:
Biotechnology
68 analysts
Strong Buy
Target: $5.38 (+773.38%)

Market Cap

$58M

Free Cash Flow Yield

-56.68%

Beta (5Y)

0.76

Price Chart

Valuation
Market Cap$58M
P/B1.08
Profitability
EBITDA-$44M
EPS-$0.35
Financial Health
Free Cash Flow Yield-56.68%
Growth & Risk
Beta (5Y)0.76
Sharpe Ratio0.16